Healthcare - Medical - Devices - NASDAQ - US
$ 1.595
-14 %
$ 437 M
Market Cap
-1.09
P/E
Price Target
Average
88.09%
Revenue Forecast
Estimate
20.12%
EBIT
Estimate
3.18%
Net Income
Estimate
25.63%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Pacific Biosciences of California, Inc.
Wall Street analysts predict an average 1-year price target for PACB of $3 , with forecasts ranging from a low of $2 to a high of $4 .
PACB Lowest Price Target
Wall Street Target
2 USD
25.39%
PACB Average Price Target
Wall Street Target
3 USD
88.09%
PACB Highest Price Target
Wall Street Target
4 USD
150.78%
REVENUE FORECAST
Revenue Forecast Chart PACB
EBIT FORECAST
EBIT Forecast Chart PACB
NET INCOME FORECAST
Net Income Chart PACB